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Abstract
Objective: Historically, changes in normal thyroid uptake values for iodine have been reported in different 
geographical areas. These changes have been linked to geographical and chronological fluctuations in dietary 
iodine intake in different populations. Namibia is a country with mixed ethnicity, with access to dietary iodine in 
table salt. Despite historical reports on deviating normal thyroid uptake values (emphasising the importance of 
establishing local normal reference values), the relevant Namibian authorities have never revised these reference 
values, nor have local reference values been established. The aim of this study was to establish the normal reference 
values for thyroid uptake of technetium-99m pertechnetate in the Namibian population. 
Design: Participants who were considered to be euthyroid completed a questionnaire designed to exclude 
individuals with thyroid pathologies, as well as those with renal or heart disease. 
Settings and subjects: The study cohort consisted of 76 participants (58 women and 18 men), ranging in age 
from 39-81 years. The participants were of mixed ethnicity, consisting of Hereros, Ovambos, Damaras, Namas, 
Coloureds, Caucasians and other (non-Namibian immigrants), and were from Windhoek, Namibia. Studies were 
performed at the Windhoek Central Hospital.
Outcome measures: Blood was drawn for thyroid hormone assessment. Participants were then given 100 MBq of 
technetium-99m pertechnetate intravenously, and their percentage thyroid uptake recorded after 20 minutes. 
Results: In this study, thyroid-stimulating hormone, triiodothyronine, and thyroxine levels were found to be 1.7 µIU/
ml, 4.9 pmol/ml and 10.3 pmol/ml, respectively. Analysis of the empirical data showed that the normal reference 
uptake value for technetium-99m pertechnetate in the studied population ranged between 0.04% and 2.40%.The 
fifth and 95th percentiles for pertechnetate uptake were 0.15% and 1.69%, respectively.
Conclusion: These results provide new evidence which supports the importance of periodical evaluation of normal 
thyroid uptake reference values for technetium-99m pertechnetate.
 Peer reviewed. (Submitted: 2013-01-24. Accepted: 2013-05-22.) © SEMDSA JEMDSA 2013;18(3):142-147
Introduction
The normal reference values for thyroid uptake of 
technetium-99m pertechnetate and radioactive iodine 
in euthyroid persons change with the geographical 
location, and may change from one decade to the 
next. Throughout history, fluctuations in the normal 
reference values have been documented. These 
reports show the importance of periodic evaluation of 
normal reference values for thyroid uptake. Bernard et 
al1 discovered that the uptake range found in normal 
subjects deviated significantly from the traditional 
radioactive iodine ranges that were routinely used. 
In California, Blum and Chandra2 likewise reported 
that several laboratories had recorded a lowered 
normal human thyroid gland uptake of radioactive 
iodine. Similarly, in Minneapolis, Wong and Schultz3 
reported that normal ranges of radioiodine uptake 
had deviated twice in a span of 20 years. In a relatively 
stable population in Fort Smith, Arakansas, Culp and 
Huskison4 also reported that there was a deviation in 
the normal uptake values of iodine-131. However, in 
Boston, Anderson and Powsner5 observed stability in 
the normal reference values of radioactive iodine 
over 16 years. It has also been demonstrated that it is 
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important to establish normal thyroid uptake values on 
a regional basis, since normal limits vary within different 
geographical areas,6 according to Nelson et al.
Geographical location-specific reference data for 
thyroid uptake of technetium-99m pertechnetate are 
rare and vary significantly.7-9 Therefore, there is a need 
to establish reference values for each location.There 
are no reported reference values for technetium-99m 
pertechnetate uptake for Namibia. The reference 
range routinely used in Namibia for thyroid uptake 
of technetium-99m pertechnetate is 0.75-4% of the 
administered activity after 20 minutes. This range was 
adopted from guidelines of the International Society 
of Nuclear Medicine10 as it is not always convenient 
for each nuclear medicine facility to determine 
technetium-99m pertechnetate uptake in normal 
euthyroid individuals.
This study was limited to the Khomas region as it was the 
only region in Namibia that had a nuclear medicine 
department at the time of the research study which 
was from August to December 2011. The present 
study sought to test the hypothesis that thyroid uptake 
reference values for technetium-99m pertechnetate 
in the Namibian population deviate from available 
international normal reference values.
Euthyroid individuals were identified to determine 
a normal reference range for thyroid uptake of 
technetium-99m pertechnetate for the Namibian 
population. A normative or norm-referenced research 
design was used which focused on establishing the 
normal reference values for specific variables to serve 
as a guide for diagnosis and treatment planning. A 
cross-sectional approach, which focused on a small 
subpopulation at one point in time in order to draw 
conclusions about the whole population, was adopted. 
Furthermore, a prospective data collection method 
was used to record the research variables. The study 
was non-therapeutic, and the participants received 
very low doses of ionising radiation.
Method
Seventy-six participants (58 women and 18 men), 
ranging in age from 39-81 years, living in the Khomas 
region of Windhoek, Namibia, were recruited. Three 
sampling methods, namely purposive, nonprobability 
and snowball sampling, were used. Each subject was 
selected by using a questionnaire which evaluated 
the clinical history, history of iodinated-contrast 
radiographic procedures and a physical examination, 
to exclude those with cardiac, renal or thyroid 
disease. Individuals with iodine contamination were 
also excluded. Participants taking medication known 
to affect thyroid function were excluded from the 
study. The laboratory assessment of thyroid function 
was obtained via serum measurements of thyroid-
stimulating hormone, free triiodothyronine, and free 
thyroxine. The study protocol was approved by the 
ethics committees of the Cape Peninsula University of 
Technology, the Ministry of Health and Social Services 
of Namibia, the Namibian Institute of Pathology and 
the National Radiation Protection Authority of Namibia.
Each participant received 100 MBq of technetium-99m 
pertechnetate intravenously. The percentage uptake 
of technetium-99m pertechnetate by the thyroid gland 
was determined at 20 minutes, using scintigraphic 
imaging techniques. A Nucline™ Spirit DH-V dual-
head digital gamma camera equipped with a low-
energy, high-resolution parallel hole collimator was 
Figure 1 a: Irregular region of interest drawn around the thyroid 
gland (yellow) and rectangular background region of interest 
under the thyroid gland (red). The thyroid uptake was 1.09%
Figure 1 b (right): A representative image of an extremely low 
thyroid uptake of 0.25%
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used. Images were obtained on a 128 × 128 pixel 
matrix, with a zoom of 1.8. Images of the syringe were 
obtained before and after injection of technetium-
99m pertechnetate to determine the exact amount 
of administered activity for the calculation of thyroid 
uptake. Images of the syringe and anterior neck 
were acquired for 60 seconds. A control image of the 
injection site was obtained to determine if there was 
any extravasation that would invalidate the thyroid 
uptake percentage calculation. 
The total number of counts was calculated by drawing 
an irregular region of interest (yellow) around the borders 
of the thyroid gland (Figure 1a). A rectangular region 
of interest (red), with a width that was approximately 
equal to that of the thyroid gland, was drawn under 
the gland to represent the background (Figure 1a). To 
demonstrate that the thyroid could be visualised at 
very low uptake, and that the respective images were 
of acceptable quality, an image that corresponded 
with an uptake of 0.25% was obtained (Figure 1b).
Pre-injection syringe counts (F) and the post-injection 
syringe counts (E) were obtained from the images. All 
counts were corrected for the decay of technetium-
99m pertechnetate and acquisition time. 
The thyroid uptake of technetium-99m pertechnetate 
for each participant was calculated using the following 
formula:
% uptake = [(TH – BK)/(F – E)] x 100%
where TH and BK are the thyroid and background 
counts, respectively.
Results
The study comprised 76 research participants (58 
women and 18 men). Only participants aged 39 years 
and older were included in the study because of 
radiation safety concerns. Participants were selected 
from a population of mixed ethnicity consisting of 
Hereros, Ovambos, Damaras, Namas, Coloureds, 
Caucasians and other non-Namibian immigrants. The 
ethnic distribution of the 76 participants, as illustrated 
in Figure 2, included 40.8% (n = 31) Ovambos, 23.7 % (n 
= 18) Hereros, 14.5% (n = 11)  , 7.9% (n = 6) Namas, 6.6% 
(n = 5) Damaras, 5.2% (n = 4) Caucasians, and 1.3% (n 
= 1) others.11 
The questionnaire comprised two sections on medical 
history and source of dietary iodine. Analysis of the 
medical history noted that participants had no past 
thyroid disorders, and were not suspected of having any 
thyroid disorders at the time of the study. Participants 
were not exposed to iodinated contrast media or 
radionuclides prior to or during the investigation. None 
of them had a history of taking heart medication two 
years before the study. None of the female participants 
had used any iodine-containing vaginal douche, or 
were pregnant or nursing at the time of investigation. 
None of the participants were smokers.
The different ethnic groups followed unique diets. All 
of the participants used iodised table salt on a daily 
basis. Twenty-three participants took multivitamins 
and minerals on a daily basis, and these included Q 
10 Fatigue®, Dynamisan®, Pharmaton®, Glucosamin®, 
Sentrum®, Bico®, vitamin C, Beta Vita®, Vitathion®, 
Vitamin A to Z®, and Vital®. Twenty of the participants 
took energy supplements on a daily basis. These 
supplements did not contain high levels of iodine, 
and were found to contribute less than the daily 
recommended intake of 0.25 mg. All of the participants 
consumed fresh milk in their tea or coffee on a daily 
basis. Cheese, yoghurt, ice cream, frozen yoghurt 
and eggs were only eaten occasionally. All of the 
participants consumed at least two slices of bread 
daily. From an analysis of the dietary iodine section of 
the questionnaire, it emerged that the main sources 
of dietary iodine for this population were iodised table 
salt, dairy products and bread.
No enlarged thyroid glands or nodules were palpated 
on clinical evaluation of the 76 euthyroid participants. 
These findings were further confirmed by scintigraphic 
images which did not show thyromegally or nodules.
The results of the serum thyroid hormone levels are 
summarised in Table I. All levels of thyroid hormones 
were within normal ranges.
The thyroid uptake of technetium-99 m pertechnetate 
ranged from 0.15-2.14%. The characteristics of the 76 
euthyroid participants at the Windhoek Central Hospital’s 
Department of Nuclear Medicine are summarised 
in Table II. The mean [± standard deviation (SD)] 
technetium-99m pertechnetate uptake for males and 
females was 0.65 ± 0.38 and 0.81± 0.47%, respectively. 
When combined, the average pertechnetate uptake in 
the study cohort was 0.78 ± 0.45%.
Ovambo
Herero
Coloureds
Namas
Damara
Caucasians
Other
Figure 2: The distribution of the ethnic groups: Ovambos (n = 31), 
Hereros (n = 18), Coloureds (n = 11), Namas (n = 6), Damaras  
(n = 5), Caucasians (n = 4), and others (n = 1)   
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The gender-specific data were compared to the whole 
euthyroid research population, as illustrated in Figure 
3. The data show that gender did not seem to play 
a significant role in euthyroid pertechnetate uptake, 
but normal values appeared to be marginally lower in 
men (0.65 ± 0.38%) than in women (0.81 ± 0.47%). To 
test whether or not ethnicity played a role in euthyroid 
uptake of technetium-99m pertechnetate, ethnic 
uptake data were compared with those pertaining 
to the population (Figure 4). No significant differences 
were apparent among the ethnic groups, relative to 
the representative population.
To determine if technetium-99m pertechnetate uptake 
was normally distributed in the Namibian population, 
uptake values were grouped over intervals of 0.25% 
(0-0.25, > 0.25-0.50, > 0.50-0.75 and > 2-2.25%), and a 
histogram mean uptake for the intervals generated 
(Figure 5). These data clearly show that euthyroid 
pertechnetate uptake in this population was skewed 
and not normally distributed. Twenty-six per cent of the 
participants (n = 20) had extremely low pertechnetate 
uptake (≤ 0.5%). Half of the participants (n = 38) had 
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Figure 3: Gender comparison of technetium-99m pertechnetate 
uptake in an euthyroid population
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Figure 5: Frequency histogram of mean percentage uptake of 
technetium-99m pertechnetate in the Namibian population
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Figure 6: Cumulative frequency polygon, showing the 
percentiles of mean euthyroid uptake of technetium-99m 
pertechnetate in the Namibian population
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Figure 4: Ethnic comparison of technetium-99m pertechnetate 
uptake in an euthyroid population
Table I: Thyroid hormone function data for the normal participants
Group Total TSH
Mean ± SD
TS
Mean ± SD
T4
Mean ± SD
Women 58 1.58 ± 0.76 4.82 ± 0.80 10.36 ± 1.84
Men 18 2.06 ± 1.40 4.96 ± 0.79 10.17 ± 1.77
Population 76 1.70 ± 0.96 4.86 ± 0.79 10.32 ± 1.82
Normal laboratory range 0.34-5.60 µIU/ml 3.80-6 pmol/l 7.2-21.1 pmol/l
TSH: thyroid-stimulating hormone, SD: standard deviation, T3: triiodothyronine, T4: thyroxine
Table II: Means and ranges of technetium-99m pertechnetate uptake in euthyroid Namibian participants
Group Total % Mean age (years) Age range (years) % uptake range % uptake mean 
± SD
% uptake 95% CI
Men 18 23.7 49.83 39-67 0.31-1.07 0.65 ± 0.38 0.50-0.88
Women 58 76.3 49.28 41-81 0.34-1.28 0.81 ± 0.47 0.68-0.93
Population 76 100 49.41 39-81 0.31-1.28 0.78 ± 0.45 0.33-1.23
CI: confidence interval, SD: standard deviation
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uptake values below the departmental lower limit of 
0.75%. The remaining 50% of participants emerged 
with uptake values within the international and 
departmental reference range of 0.75-4%.
The red bars represent participants with uptake values 
less than the departmental lower limit of 0.75%
Owing to skewness in uptake distribution, the 95% 
confidence interval and the mean (± SD) were 
considered to be inappropriate indicators of the 
normal reference range. To determine the reference 
range for technetium-99m pertechnetate, the data 
in Figure 5 were plotted as a cumulative frequency 
curve, as presented in Figure 6. The fifth and 95th 
percentiles were then determined to represent the 
normal reference range for the Namibian population. 
The fifth and 95th percentiles were found to be in the 
range of 0.15-1.69%.
Discussion
In this study, the range of euthyroid uptake of derived 
technetium-99m pertechnetate differed significantly 
from the internationally accepted normal reference 
values (0.75-4%) that are currently used by the 
Department of Nuclear Medicine of the Windhoek 
Central Hospital, Namibia. In this study, the reference 
uptake values were found to range from 0.15-1.69%. 
The data in Figure 5 demonstrate that as many as 
50% of participants had uptake values below 0.75%. 
Furthermore, approximately half of these presented 
with a very low uptake of ≤ 0.50%. On the basis of the 
departmental reference values, these participants 
would have been diagnosed as abnormal. Although 
these data overlap considerably with other ranges 
reported elsewhere,7-9 they differ significantly. 
For instance, normal thyroid reference values for 
technetium-99m pertechnetate uptake as reported by 
Ramos et al7 and Anjos et al9 were 0.4-1.7% and 0.56-
0.80%, respectively.
Historically, thyroid uptake normal values for 
radioiodine have shown predominant decreases. A 
marked lowering of normal values has been reported 
by different groups.1,12,13 Others have reported upward 
trends in reference values, compared to those 
established in earlier years.3 More recently, Al-Muqbel 
and Tashtoush14 noted a lowering in normal values for 
the Jordan population. These values were comparable 
to those reported for American populations.2,15 
Milakovic et al16 also reported lower values than those 
obtained half a century ago for a Swedish population. 
By contrast, the values obtained by Gonzalez et 
al17 for Chile did not differ from their departmental 
reference values. Some researchers have suggested 
that medication that contains supplements may be 
responsible for the lowering of normal values of iodine. 
Anderson and Powsner5 demonstrated that an increase 
in iodine ingestion was a major cause of decreased 
reference values.
From the current findings, gender, age and ethnicity 
did not appear to significantly influence euthyroid 
uptake of technetium-99m pertechnetate. The reasons 
for the extremely low pertechnetate uptake values 
encountered in this study are not clear, but may relate 
to diet and dietary supplementation. Vitamins and 
minerals taken by participants in this study did not 
contain high levels of iodine. However, the continuous 
intake of iodised table salt could have reduced thyroid 
uptake of technetium-99m pertechnetate. This notion 
is supported by the fact that thyroid uptake of iodine 
directly correlates with technetium-99m pertechnetate 
uptake,18 implying that the mode by which the two 
radiochemicals are taken up by the thyroid is similar. In an 
earlier study, Reinhardt et al19 demonstrated that thyroid 
uptake of pertechnetate inversely correlated with iodine 
intake, suggesting that preloading the thyroid with cold 
iodine can significantly reduce the subsequent uptake 
of technetium-99m pertechnetate. Therefore, it is not 
surprising that thyroid uptake pertechnetate tended to 
be low in a population that supplemented its diet with 
the daily intake of iodised salt.
Conclusion
There was a marked lowering of normal thyroid uptake 
values for technetium-99m pertechnetate in Namibia, 
compared to those that are traditionally used in the 
clinic. It is recommended that these new reference 
values are used for the Namibian population. The 
data obtained in this study provide new evidence 
that emphasises the importance of periodic, location-
specific monitoring of thyroid uptake of technetium-
99m pertechnetate to maintain quality assurance.
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